title: Anti-tumour-necrosis-factor-alpha agents and the heart: beyond left ventricular systolic dysfunction?
authors.forename: Vassilis
authors.initials: V
authors.lastname: Vassiliou
authors.forename: Eleana
authors.initials: E
authors.lastname: Ntatsaki
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D003937:Diagnosis, Differential; D004452:Echocardiography; D004697:Endocarditis, Bacterial / Q000139:chemically induced* / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D008297:Male; D011565:Psoriasis / Q000188:drug therapy
chemical_list: D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab